Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Second Dose Varicella Biken Vaccine in Children
NCT00830648Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2009
- Primary completion
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Varicella Biken in varicella (VZV), sponsored by Sanofi. Primary endpoint: Safety after administration of Varicella vaccine at 1 month. Started Jan 2009; status: completed.
02
Drugs
Varicella Biken
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00830648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830648.